OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 13.35
+0.05 (0.38%)
At close: Mar 27, 2026
OK Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 82.45 | 93.98 | 2.95 | 143.46 | 43.46 |
Depreciation & Amortization | 93.61 | 72.15 | 75.55 | 67.88 | 55.78 |
Other Amortization | - | 0.27 | 0 | 0 | 0.1 |
Loss (Gain) From Sale of Assets | -2.96 | -2.31 | -2.78 | -1.4 | -0.92 |
Asset Writedown & Restructuring Costs | - | - | - | 6 | - |
Loss (Gain) From Sale of Investments | -1.41 | 6.97 | -2.33 | 2.44 | 2.37 |
Loss (Gain) on Equity Investments | -0.58 | -5.11 | -5.33 | -7.43 | -24.65 |
Stock-Based Compensation | 14.69 | 19.64 | 3.26 | - | 3.4 |
Provision & Write-off of Bad Debts | 11.24 | -10.45 | 21.25 | 31.27 | 6.68 |
Other Operating Activities | -13.05 | 52.81 | -43.45 | 55.05 | 2.35 |
Change in Accounts Receivable | 165.45 | -41.92 | -77.45 | -71.36 | -92.09 |
Change in Inventory | 70.83 | -41.14 | 28.9 | -47.31 | -26.57 |
Change in Accounts Payable | -77.7 | -80.74 | -45.51 | 6.1 | 32.85 |
Change in Unearned Revenue | -25.4 | -41.88 | 22.49 | 13.96 | 13.72 |
Change in Other Net Operating Assets | 1.68 | 17.37 | 25.38 | 41.86 | 5.4 |
Operating Cash Flow | 318.86 | 65.9 | 2.93 | 240.53 | 21.9 |
Operating Cash Flow Growth | 383.83% | 2146.95% | -98.78% | 998.49% | -85.23% |
Capital Expenditures | -400.48 | -376.69 | -429.68 | -286.84 | -79.06 |
Sale of Property, Plant & Equipment | 4.17 | 10.94 | 12.11 | 5.09 | 3.11 |
Cash Acquisitions | - | -136.91 | - | - | - |
Sale (Purchase) of Intangibles | -0.34 | -0.44 | -7.4 | -7.4 | -7.41 |
Investment in Securities | 2 | 28.76 | 66.6 | -5 | -61.03 |
Other Investing Activities | -3.85 | 29.42 | -0.01 | -0.08 | -30.08 |
Investing Cash Flow | -398.5 | -444.93 | -358.38 | -294.23 | -174.46 |
Short-Term Debt Issued | 3,350 | 1,270 | 1,780 | 1,745 | 1,282 |
Long-Term Debt Issued | 294.4 | 239.8 | - | 294.87 | 292.28 |
Total Debt Issued | 3,644 | 1,510 | 1,780 | 2,040 | 1,574 |
Short-Term Debt Repaid | -3,360 | -1,120 | -1,811 | -1,746 | -1,267 |
Long-Term Debt Repaid | -68.88 | -13.78 | -12.6 | -148.36 | -17.02 |
Total Debt Repaid | -3,429 | -1,134 | -1,823 | -1,895 | -1,284 |
Net Debt Issued (Repaid) | 215.52 | 375.99 | -43.3 | 145.2 | 290.3 |
Issuance of Common Stock | - | - | 270 | - | 27.24 |
Repurchase of Common Stock | -33.31 | - | - | - | - |
Common Dividends Paid | -43.79 | -44.12 | -144.64 | -94.93 | -131.85 |
Other Financing Activities | -24.68 | 6.15 | - | - | - |
Financing Cash Flow | 113.75 | 338.03 | 82.06 | 50.27 | 185.69 |
Foreign Exchange Rate Adjustments | 2.9 | -4.58 | - | - | - |
Net Cash Flow | 37.02 | -45.58 | -273.39 | -3.44 | 33.13 |
Free Cash Flow | -81.62 | -310.79 | -426.74 | -46.31 | -57.16 |
Free Cash Flow Margin | -5.24% | -18.61% | -35.80% | -3.12% | -4.52% |
Free Cash Flow Per Share | -0.56 | -2.12 | -3.32 | -0.36 | -0.48 |
Cash Interest Paid | 10.11 | 5.19 | 5.63 | 4.56 | 3.88 |
Cash Income Tax Paid | 35.27 | -8.99 | 71.36 | 11.77 | 39.26 |
Levered Free Cash Flow | -122.78 | -443.16 | -526.99 | -150.13 | -261 |
Unlevered Free Cash Flow | -115.95 | -439.27 | -521.37 | -142.99 | -255.95 |
Change in Working Capital | 134.86 | -162.05 | -46.19 | -56.75 | -66.68 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.